An appellate court panel ruled Tuesday that drug manufacturers may not impose 340B rebates without approval from the U.S. Department of Health and Human Services (HHS). | The ruling upheld a previous ...

LITTLE ROCK, Ark.- Arkansas Attorney General Tim Griffin will hold a press conference Wednesday morning to make an ...

The U.S. District Court for the District of Columbia July 21 upheld a lower court’s decision that Section 340B of the Public ...

Republished with permission from The Buckeye Flame. After more than 40 years of AIDS activism, Gil Kudrin had thought he’d seen it all – until he started receiving panicked phone calls over the past ...

AHA responds to Information Collection Request about the Health Resources and Services Administration’s proposed 340B Rebate Model Program.

The federal drug pricing program 340B helps hospitals and clinics in Virginia and across the nation care for underserved patients by requiring pharmaceutical companies to offer prescription discounts ...

The 340B Drug Pricing Program may be partly driving U.S. hospital consolidation and worsening affordability for patients, ...

CMS would set 340B drug payment at ASP–33.4%, lowering Medicare and beneficiary drug outlays while redistributing equivalent dollars to nondrug OPPS payments under statutory budget neutrality. A CMS ...

In today's Pharmaceutical Executive Daily, Eli Lilly and Abbisko Therapeutics announce a new strategic research collaboration in which Abbisko will leverage its early-stage drug discovery platform to ...

After more than 40 years of AIDS activism, Gil Kudrin had thought he’d seen it all – until he started receiving panicked phone calls over the past few weeks from HIV care providers throughout ...

From the first lawsuit to Lilly’s ultimatum: 18 months that reshaped the 340B program. For more than a year, major drugmakers have been pushing to replace the 340B program’s longstanding upfront ...